Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR


PTI | New Delhi | Updated: 12-05-2021 00:16 IST | Created: 12-05-2021 00:16 IST
Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR
  • Country:
  • India

Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback